These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. No evidence of an additive inhibitory feeding effect following PP and PYY 3-36 administration. Neary NM; McGowan BM; Monteiro MP; Jesudason DR; Ghatei MA; Bloom SR Int J Obes (Lond); 2008 Sep; 32(9):1438-40. PubMed ID: 18607381 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of food intake in obese subjects by peptide YY3-36. Batterham RL; Cohen MA; Ellis SM; Le Roux CW; Withers DJ; Frost GS; Ghatei MA; Bloom SR N Engl J Med; 2003 Sep; 349(10):941-8. PubMed ID: 12954742 [TBL] [Abstract][Full Text] [Related]
7. Peripheral administration of pancreatic polypeptide inhibits components of food-intake behavior in dogs. Akerberg H; Meyerson B; Sallander M; Lagerstedt AS; Hedhammar A; Larhammar D Peptides; 2010 Jun; 31(6):1055-61. PubMed ID: 20338207 [TBL] [Abstract][Full Text] [Related]
8. Effects of exercise on gut peptides, energy intake and appetite. Martins C; Morgan LM; Bloom SR; Robertson MD J Endocrinol; 2007 May; 193(2):251-8. PubMed ID: 17470516 [TBL] [Abstract][Full Text] [Related]
9. Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure. Bagger JI; Holst JJ; Hartmann B; Andersen B; Knop FK; Vilsbøll T J Clin Endocrinol Metab; 2015 Dec; 100(12):4541-52. PubMed ID: 26445112 [TBL] [Abstract][Full Text] [Related]
10. A role for pancreatic polypeptide in the regulation of gastric emptying and short-term metabolic control. Schmidt PT; Näslund E; Grybäck P; Jacobsson H; Holst JJ; Hilsted L; Hellström PM J Clin Endocrinol Metab; 2005 Sep; 90(9):5241-6. PubMed ID: 15998783 [TBL] [Abstract][Full Text] [Related]
11. Effects of PYY3-36 and GLP-1 on energy intake, energy expenditure, and appetite in overweight men. Schmidt JB; Gregersen NT; Pedersen SD; Arentoft JL; Ritz C; Schwartz TW; Holst JJ; Astrup A; Sjödin A Am J Physiol Endocrinol Metab; 2014 Jun; 306(11):E1248-56. PubMed ID: 24735885 [TBL] [Abstract][Full Text] [Related]
12. Ghrelin increases food intake in obese as well as lean subjects. Druce MR; Wren AM; Park AJ; Milton JE; Patterson M; Frost G; Ghatei MA; Small C; Bloom SR Int J Obes (Lond); 2005 Sep; 29(9):1130-6. PubMed ID: 15917842 [TBL] [Abstract][Full Text] [Related]
13. The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity. Flint A; Raben A; Ersbøll AK; Holst JJ; Astrup A Int J Obes Relat Metab Disord; 2001 Jun; 25(6):781-92. PubMed ID: 11439290 [TBL] [Abstract][Full Text] [Related]
14. Effects of intraduodenal infusion of L-tryptophan on ad libitum eating, antropyloroduodenal motility, glycemia, insulinemia, and gut peptide secretion in healthy men. Steinert RE; Luscombe-Marsh ND; Little TJ; Standfield S; Otto B; Horowitz M; Feinle-Bisset C J Clin Endocrinol Metab; 2014 Sep; 99(9):3275-84. PubMed ID: 24926954 [TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. Verdich C; Flint A; Gutzwiller JP; Näslund E; Beglinger C; Hellström PM; Long SJ; Morgan LM; Holst JJ; Astrup A J Clin Endocrinol Metab; 2001 Sep; 86(9):4382-9. PubMed ID: 11549680 [TBL] [Abstract][Full Text] [Related]
16. Independent and combined effects of eating rate and energy density on energy intake, appetite, and gut hormones. Karl JP; Young AJ; Rood JC; Montain SJ Obesity (Silver Spring); 2013 Mar; 21(3):E244-52. PubMed ID: 23592679 [TBL] [Abstract][Full Text] [Related]
17. Investigation of the medium-term effects of Olibratrade mark fat emulsion on food intake in non-obese subjects. Logan CM; McCaffrey TA; Wallace JM; Robson PJ; Welch RW; Dunne A; Livingstone MB Eur J Clin Nutr; 2006 Sep; 60(9):1081-91. PubMed ID: 16538239 [TBL] [Abstract][Full Text] [Related]
18. Short-term effects of sibutramine (Reductil) on appetite and eating behaviour and the long-term therapeutic outcome. Barkeling B; Elfhag K; Rooth P; Rössner S Int J Obes Relat Metab Disord; 2003 Jun; 27(6):693-700. PubMed ID: 12833113 [TBL] [Abstract][Full Text] [Related]
19. Effect of peptide YY3-36 on food intake in humans. Degen L; Oesch S; Casanova M; Graf S; Ketterer S; Drewe J; Beglinger C Gastroenterology; 2005 Nov; 129(5):1430-6. PubMed ID: 16285944 [TBL] [Abstract][Full Text] [Related]
20. Short-term effects of a novel fat emulsion on appetite and food intake. Diepvens K; Steijns J; Zuurendonk P; Westerterp-Plantenga MS Physiol Behav; 2008 Sep; 95(1-2):114-7. PubMed ID: 18571210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]